In severe COVID-19, high-flow vs. conventional oxygen therapy reduced intubation and time to clinical recovery at 28 d

Christopher R Carpenter; Peter A D Steel

doi:10.7326/J22-0011

In severe COVID-19, high-flow vs. conventional oxygen therapy reduced intubation and time to clinical recovery at 28 d

Ann Intern Med. 2022 Apr;175(4):JC38. doi: 10.7326/J22-0011. Epub 2022 Apr 5.

Authors

Christopher R Carpenter¹, Peter A D Steel²

Affiliations

¹ Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA (C.R.C.).
² New York Presbyterian Hospital--Weill Cornell, New York City, New York, USA (P.A.S.).

PMID: 35377724
DOI: 10.7326/J22-0011

Abstract

Ospina-Tascón GA, Calderón-Tapia LE, García AF, et al. Effect of high-flow oxygen therapy vs conventional oxygen therapy on invasive mechanical ventilation and clinical recovery in patients with severe COVID-19: a randomized clinical trial. JAMA. 2021;326:2161-71. 34874419.

Publication types

Randomized Controlled Trial
Comment

MeSH terms

COVID-19* / therapy
Humans
Intubation, Intratracheal
Oxygen / therapeutic use
Oxygen Inhalation Therapy
Respiratory Insufficiency* / therapy

Substances

Oxygen